Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting

• Natasha van’t Boveneind-Vrubleuskaya ,

  * E-mail: natasha.boveneind@ggdhaaglanden.nl

  Affiliations Department of Public Health TB Control, Metropolitan Public Health Service, The Hague, The Netherlands, University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

  http://orcid.org/0000-0002-1682-8457

  ⨯
• Alper Daskapan,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

  ⨯
• Jos G. W. Kosterink,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

  ⨯
• Tjip S. van der Werf,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands

  ⨯
• Susan van den Hof,

  Affiliations KNCV Tuberculosis Foundation, The Hague, The Netherlands, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands

  ⨯
• Jan-Willem C. Alffenaar

  Affiliation University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

  ⨯